Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir with Bortezomib and Dexamethasone in Refractory Myeloma
NCT02188537Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Dec 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelfinavir in multiple myeloma (MM), sponsored by Swiss Group for Clinical Cancer Research. Started Dec 2014; status: completed.
02
Drugs
nelfinavir
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02188537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188537.